ReviewBiomedicines2024

Advanced Glycation End-Products Acting as Immunomodulators for Chronic Inflammation, Inflammaging and Carcinogenesis in Patients with Diabetes and Immune-Related Diseases.

Chieh-Yu Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.